Sur Tatil Evleri Gayrimenkul Yatirim Ortakligi Anonim Sirketi (IST:SURGY)
42.22
+0.82 (1.98%)
At close: Apr 3, 2025, 6:00 PM GMT+3
IST:SURGY Statistics
Total Valuation
IST:SURGY has a market cap or net worth of TRY 7.17 billion. The enterprise value is 6.92 billion.
Market Cap | 7.17B |
Enterprise Value | 6.92B |
Important Dates
The next estimated earnings date is Monday, April 28, 2025.
Earnings Date | Apr 28, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
IST:SURGY has 167.50 million shares outstanding.
Current Share Class | n/a |
Shares Outstanding | 167.50M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | 0.05% |
Float | 45.00M |
Valuation Ratios
The trailing PE ratio is 21.82.
Price/FFO Ratio | n/a |
Price/AFFO Ratio | n/a |
PE Ratio | 21.82 |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | 1.16 |
P/TBV Ratio | 1.16 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 21.06 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 18.24, with a Debt / Equity ratio of 0.01.
Current Ratio | 18.24 |
Quick Ratio | 4.21 |
Debt / Equity | 0.01 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -185.00 |
Financial Efficiency
Return on equity (ROE) is 5.00% and return on invested capital (ROIC) is -1.91%.
Return on Equity (ROE) | 5.00% |
Return on Assets (ROA) | -1.38% |
Return on Invested Capital (ROIC) | -1.91% |
Return on Capital Employed (ROCE) | -2.05% |
Revenue Per Employee | n/a |
Profits Per Employee | 32.88M |
Employee Count | 10 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +6.03% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +6.03% |
50-Day Moving Average | 41.60 |
200-Day Moving Average | 52.82 |
Relative Strength Index (RSI) | 55.57 |
Average Volume (20 Days) | 1,742,044 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -201.90M |
Pretax Income | 791.71M |
Net Income | 328.76M |
EBITDA | -200.23M |
EBIT | -201.90M |
Earnings Per Share (EPS) | 1.96 |
Balance Sheet
The company has 289.25 million in cash and 40.09 million in debt, giving a net cash position of 249.16 million or 1.49 per share.
Cash & Cash Equivalents | 289.25M |
Total Debt | 40.09M |
Net Cash | 249.16M |
Net Cash Per Share | 1.49 |
Equity (Book Value) | 6.17B |
Book Value Per Share | 36.85 |
Working Capital | 2.24B |
Cash Flow
Operating Cash Flow | -468.42M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
IST:SURGY does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | 4.58% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |